Company Filing History:
Years Active: 2020-2022
Title: Yanshen Kang: Innovator in Therapeutic Antibodies
Introduction
Yanshen Kang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology through his innovative work on therapeutic antibodies. With a total of 2 patents, his research focuses on advancing cancer treatment and diagnostics.
Latest Patents
Yanshen Kang's latest patents include the development of Anti-PD-L1 antibodies and their use as therapeutics and diagnostics. These antibodies specifically bind to Programmed Death-1 (PD1, Pdcd-1, or CD279) ligand (PD-L1) and inhibit PD-L1-mediated cellular signaling and activities in immune cells. The patents detail antibodies that bind to a set of amino acid residues required for ligand binding, with applications in treating or diagnosing cancer, infectious diseases, or other pathological disorders modulated by PD-L1-mediated functions.
Career Highlights
Yanshen Kang is associated with Beigene, Ltd., a leading biotechnology company focused on developing innovative medicines for cancer treatment. His work has been instrumental in advancing therapeutic options for patients.
Collaborations
Some of Yanshen Kang's notable coworkers include Kang Li and Jing Song, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Yanshen Kang's contributions to the field of therapeutic antibodies highlight his role as an innovator in medical science. His work continues to pave the way for advancements in cancer treatment and diagnostics.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.